课题基金 / 基金详情

Gnotobiotics, Microbiology and Metagenomics Core

Gnotobiotics, Microbiology and Metagenomics Core
知生菌、微生物学和宏基因组学核心
批准号:
10625998
负责人:
WAYNE I LENCER
金额:
$27.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-09-01 至 2026-03-31

项目摘要

项目成果

WAYNE I LENCER的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要: Gnotobiotics,微生物学和宏基因组学核心(核心D),支持研究人员研究 微生物群在健康和疾病中的功能作用。核心D已经支持了超过100个感兴趣的团体, 评价宿主的微生物群影响宿主生理的作用机制, 病理生理过程 我们的资源包括微生物培养,表型分析,原发性 用于微生物代谢产物谱的样品,并为功能研究开发定义的财团,临床实验室 (CLIA)支持以微生物组为重点的临床试验的单位,基于序列分析的分子单位, 用于动物模型体内研究的无菌(无菌)小鼠设施,一个代谢单位, 小鼠代谢笼,身体组成和代谢研究,以及计算单元, 进行新的算法开发,以评估微生物群的纵向动态, 用于宿主微生物群研究的实验设计。 核心D为大波士顿地区的多个学术中心提供支持。
英文摘要
Project Summary: The Gnotobiotics, Microbiology and Metagenomics Core (Core D), supports investigators studying functional roles of the microbiota in health and disease. Core D has supported >100 groups interested in evaluating mechanisms of action by which the host’s microbiota affects host physiologic and pathophysiologic processes. Our resources include a Microbiology Unit for microbiologic culturing, phenotyping, analysis of primary samples for microbial metabolite profiles, and develop defined consortia for functional studies, a Clinical Lab (CLIA) Unit to support microbiome-focused clinical trials, a Molecular Unit for sequence-based analyses, a Gnotobiotic (germfree) mouse facility for in vivo studies in animal models, a Metabolic Unit to support mouse metabolic cage, body composition and metabolism studies, and a Computational Unit which undertakes novel algorithmic development to evaluate longitudinal dynamics of the microbiota and assist users in experimental design for host-microbiota studies. Core D provides support to multiple academic centers in the greater Boston area.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10214604
  • 项目类别:
  • 资助金额:
    $51.69万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10626015
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10405643
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Intestinal Disease-enterocyte toxin interaction
  • 批准号:
    9263933
  • 项目类别:
  • 资助金额:
    $71.69万
  • 财政年份:
    2016
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
海外基金